Key result
L-arginine supplementation at 2 and 4 g/day significantly reduced systolic blood pressure by up to 12.3% during rest, exercise, and recovery in hypertensive men.
Why the study?
Does L-arginine supplementation reduce blood pressure in hypertensive subjects with different ACE genotypes?
RCT (n=8)
No
Does L-arginine supplementation reduce blood pressure in hypertensive subjects with different ACE genotypes?
Low-dose L-arginine supplementation significantly reduces systolic blood pressure before, during, and after exercise in hypertensive patients, with the magnitude of reduction potentially dependent on ACE genotype.
Answers are grounded in this paper and cite their sources.
May lower SBP during activity in hypertensive men; hypothesis-generating and requires larger RCTs before practice change.
Purpose The present study investigated whether L-arginine supplementation reduces blood pressure (BP) in hypertensive subjects with different ACE genotypes. Methods Eight male hypertensive patients received L-arginine (2 or 4 g/day) or a placebo for a period of 4 days prior an exercise test. Statistical analysis consisted of one-way analysis of variance. Results L-arginine supplementation induced a statistically significant (p > 0.05) reduction in systolic BP measured during rest (reductions of 7.8% and 12.3% with 2 and 4 g/day, respectively), exercise (reductions of 11.8% and 10.4% with 2 and 4 g/day, respectively), and recovery (reductions of 11.7% and 10.7% with 2 and 4 g/day, respectively). The observed magnitude of BP reduction suggests an association with ACE polymorphism; a larger effect was seen with the II and DI genotypes compared with the DD genotype (II: 121 mmHg and DI: 133 mmHg vs. DD: 144 mmHg). Conclusions The results showed that L-arginine supplementation at low doses was efficient in reducing BP and that vasodilator actions that occurred through the secretion of nitric oxide might be ACE genotype dependent.
No takes yet. Share an insight, caveat, or question.
Malfatti et al. (2014) conducted an RCT in Hypertension (n=8). L-arginine vs. Placebo was evaluated on Systolic blood pressure reduction during rest, exercise, and recovery (p=<0.05). L-arginine supplementation at 2 and 4 g/day significantly reduced systolic blood pressure by up to 12.3% during rest, exercise, and recovery in hypertensive men.
Synapse has enriched 10 related papers. Consider them for comparative context: